International Standard Serial Number (ISSN)
publication venue for
Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs
A cholesterol-lowering VLP vaccine that targets PCSK9.
Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2.
Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing.
A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants.
HIV vaccine trial willingness among injection and non-injection drug users in two urban centres, Barcelona and San Francisco.
Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses.
Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice.
HPV vaccine information-seeking behaviors among US physicians: government, media, or colleagues?
Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited.
Are young injection drug users ready and willing to participate in preventive HCV vaccine trials?